Expression of 4-1BB and 4-1BBL in Graves'Disease.

Eun Sook Kim; Hyo Won Jung; Il Sung Nam-Goong; Soon Joo Woo; Jung Il Choi; Young Il Kim

doi:10.3803/jkes.2006.21.2.116

Original Article Expression of 4-1BB and 4-1BBL in Graves'Disease.: Eun Sook Kim, Hyo Won Jung, Il Sung Nam-Goong, Soon Joo Woo, Jung Il Choi, Young Il Kim; Endocrinology and Metabolism 2006;21(2):116-124
DOI: https://doi.org/10.3803/jkes.2006.21.2.116
Published online: April 1, 2006

1,835 Views
22 Download
1 Crossref
0 Scopus

¹Department of Internal Medicine, Ulsan University Hospital, College of Medicine, Korea.
²Biomedical Research Center, Ulsan University Hospital, Korea.

Abstract

BACKGROUND
4-1BB mediated costimulatory signal is a recently identified immunotherapeutic strategy for treating autoimmune diseases without depressing the immune response. In this study, we investigated the expression of 4-1BB and 4-1BBL on the peripheral blood mononuclear cells (PBMC) and we assessed whether the serum levels of soluble (s) 4-1BB and s4-1BBL in the patients with Graves' disease (GD) and compared them with normal subjects. METHODS: Expression of 4-1BB and 4-1BBL on PBMC of GD patients was determined by flow cytometry. The concentrations of s4-1BB and s4-1BBL were assessed in the sera of GD patients by performing ELISA. RESULTS: 4-1BB was constitutively expressed on naive CD4+ and CD8+ T cells of the GD patients and this was increased by stimulation. 4-1BBL was also expressed on the antigen-presenting cells such as CD19+ B cells, monocytes and dendritic cells in GD patients. The serum levels of s4-1BB and s4-1BBL were significantly higher in GD patients than those in controls, and these levels were significantly correlated with the serum levels of thyroid-binding inhibitory immunoglobulin and free T4. CONCLUSION: These results indicate that effector T cells of GD patients can be activated through the 4-1BB-mediated costimulatory signal. Elevated s4-1BB and s4-1BBL levels in the sera of GD patients may affect modulation of the clinical course in GD patients.

Keywords: Costimulatory molecule;Graves' disease;4-1BB;4-1BBL;

Figure & Data

References

Citations

Citations to this article as recorded by

Suppression of Pathogenic Autoreactive CD4+ T Cells by CD137-mediated Expansion of CD4+CD25+ Regulatory T Cells in Graves' Disease
Eun Sook Kim, Hyo Won Jung, Jung Il Choi, Il Seung Nam-Goong, Soon Hyung Hong, Young IL Kim
Journal of Korean Endocrine Society.2007; 22(5): 332. CrossRef

Cite

Related articles

Articles

Abstract

Figure & Data

References

Citations